0
0
5/30/23 at 6:03am
Organization
Moneycontrol
Author
Moneycontrol News
34 words
0
Comments
Jubilant Pharmova attributed the net loss in the fourth quarter to an impairment charge of Rs 171 crore related to certain intangible assets.
You are the first to view
https://www.moneycontrol.com/news/business/markets/jubilant-pharmova-plunges-10-on-dismal-q4-earnings-regulatory-snags-10694961.html
Create an account
or login to join the discussion